Charles River Laboratories International Inc (NYSE:CRL) Share Price

Company Profile

Business description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact
251 Ballardvale Street
WilmingtonMA01887
USA
T: +1 781 222-6000
E: [email protected]
https://www.criver.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
20,100

Recommended

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,162.60	35.50	0.39%
CAC 40	8,358.76	3.33	-0.04%
DAX 40	25,405.34	143.70	0.57%
Dow JONES (US)	49,590.20	86.13	0.17%
FTSE 100	10,140.70	16.10	0.16%
HKSE	26,608.48	376.69	1.44%
NASDAQ	23,733.90	62.56	0.26%
Nikkei 225	53,742.93	1,803.04	3.47%
NZX 50 Index	13,655.07	28.22	-0.21%
S&P 500	6,977.27	10.99	0.16%
S&P/ASX 200	8,827.80	36.50	0.42%
SSE Composite Index	4,165.29	44.86	1.09%